• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子束治疗后正常肝组织的变化。

Normal liver tissue change after proton beam therapy.

作者信息

Fukumitsu Nobuyoshi, Takahashi Shinsei, Okumura Toshiyuki, Ishida Toshiki, Murofushi Keiko Nemoto, Ohnishi Kayoko, Aihara Teruhito, Ishikawa Hitoshi, Tsuboi Koji, Sakurai Hideyuki

机构信息

Proton Medical Research Center, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, 305-8575, Japan.

出版信息

Jpn J Radiol. 2018 Sep;36(9):559-565. doi: 10.1007/s11604-018-0757-9. Epub 2018 Jul 6.

DOI:10.1007/s11604-018-0757-9
PMID:29980916
Abstract

PURPOSE

Normal liver tissue changes after proton beam therapy (PBT) were investigated in patients at 1 and 2 years after the therapy.

MATERIALS AND METHODS

Changes in normal liver tissue volume were examined. The dose distribution of the normal liver tissue was also simulated on the follow-up CTs.

RESULTS

The normal liver tissue volume was 1149 ± 215 cm before treatment, 1089 ± 188 cm at 1 year, and 1080 ± 236 cm at 2 years after treatment. The normal liver tissue volume was increased in 10 and decreased in 20 patients at 2 years and was smaller than that before the treatment in total (P = 0.03). The simulated volume that received more than 30 Gray equivalent [V30 (cm)] at 1 year was 258 ± 187 cm and that at 2 years (244 ± 171 cm) was smaller than that before treatment (297 ± 140 cm) (P = 0.03).

CONCLUSIONS

The changes in the shape and volume of normal liver tissue are not constant, which cause a large dose distribution discrepancy in the normal liver for 2 years. Therefore, careful consideration of the dose distribution of normal liver tissue is required when planning re-irradiation.

摘要

目的

研究质子束治疗(PBT)后1年和2年患者正常肝组织的变化。

材料与方法

检查正常肝组织体积的变化。还在随访CT上模拟正常肝组织的剂量分布。

结果

治疗前正常肝组织体积为1149±215cm³,治疗后1年为1089±188cm³,治疗后2年为1080±236cm³。2年时,10例患者正常肝组织体积增加,20例患者正常肝组织体积减小,总体上小于治疗前(P = 0.03)。1年时接受超过30格雷当量[V30(cm³)]的模拟体积为258±187cm³,2年时(244±171cm³)小于治疗前(297±140cm³)(P = 0.03)。

结论

正常肝组织的形状和体积变化并不恒定,这导致2年内正常肝组织的剂量分布差异较大。因此,在计划再次放疗时,需要仔细考虑正常肝组织的剂量分布。

相似文献

1
Normal liver tissue change after proton beam therapy.质子束治疗后正常肝组织的变化。
Jpn J Radiol. 2018 Sep;36(9):559-565. doi: 10.1007/s11604-018-0757-9. Epub 2018 Jul 6.
2
Investigation of the geometric accuracy of proton beam irradiation in the liver.质子束肝脏辐照的几何精度研究。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):826-33. doi: 10.1016/j.ijrobp.2010.10.028. Epub 2011 Jan 13.
3
Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.剂量-体积直方图分析在肝细胞癌分次质子束治疗后放射性肋骨骨折的危险因素中的应用。
Acta Oncol. 2013 Apr;52(3):538-44. doi: 10.3109/0284186X.2012.718094. Epub 2012 Sep 5.
4
A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma.一种经过验证的质子束治疗补丁野方案,用于有效治疗大型肝细胞癌。
J Radiat Res. 2018 Sep 1;59(5):632-638. doi: 10.1093/jrr/rry056.
5
How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver.多小才算小?需要新的肝限制-质子治疗小正常肝肝癌患者。
PLoS One. 2018 Sep 11;13(9):e0203854. doi: 10.1371/journal.pone.0203854. eCollection 2018.
6
[Internal target volume definition using four-dimensional CT and dosimetric evaluation for hepatocellular carcinoma].[利用四维CT进行肝细胞癌的内部靶区体积定义及剂量学评估]
Ai Zheng. 2007 Jan;26(1):1-8.
7
Can We Spare the Pancreas and Other Abdominal Organs at Risk? A Comparison of Conformal Radiotherapy, Helical Tomotherapy and Proton Beam Therapy in Pediatric Irradiation.我们能否保留胰腺及其他有风险的腹部器官?儿童放疗中适形放疗、螺旋断层放疗与质子束治疗的比较。
PLoS One. 2016 Oct 20;11(10):e0164643. doi: 10.1371/journal.pone.0164643. eCollection 2016.
8
Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group.不可切除肝肿瘤患者的质子束调强放疗:质子协作组多机构前瞻性结果。
Radiat Oncol. 2020 Nov 4;15(1):255. doi: 10.1186/s13014-020-01703-3.
9
Investigation of dosimetric variations of liver radiotherapy using deformable registration of planning CT and cone-beam CT.利用计划CT与锥形束CT的可变形配准研究肝脏放射治疗的剂量学变化
J Appl Clin Med Phys. 2017 Jan;18(1):66-75. doi: 10.1002/acm2.12008. Epub 2016 Dec 5.
10
Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.肝细胞癌患者重复质子束治疗分析
Radiother Oncol. 2017 May;123(2):240-245. doi: 10.1016/j.radonc.2017.03.004. Epub 2017 Mar 30.

引用本文的文献

1
Transitions of Liver and Biliary Enzymes during Proton Beam Therapy for Hepatocellular Carcinoma.肝细胞癌质子束治疗期间肝脏和胆汁酶的变化
Cancers (Basel). 2020 Jul 8;12(7):1840. doi: 10.3390/cancers12071840.
2
Three cases of hepatocellular carcinoma treated 4 times with proton beams.三例肝细胞癌患者接受了4次质子束治疗。
Mol Clin Oncol. 2020 Jan;12(1):31-35. doi: 10.3892/mco.2019.1950. Epub 2019 Nov 18.

本文引用的文献

1
Registration error of the liver CT using deformable image registration of MIM Maestro and Velocity AI.使用MIM Maestro和Velocity AI的可变形图像配准技术对肝脏CT进行配准误差分析
BMC Med Imaging. 2017 May 4;17(1):30. doi: 10.1186/s12880-017-0202-z.
2
Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.肝细胞癌患者重复质子束治疗分析
Radiother Oncol. 2017 May;123(2):240-245. doi: 10.1016/j.radonc.2017.03.004. Epub 2017 Mar 30.
3
Comparative evaluation of target volumes defined by deformable and rigid registration of diagnostic PET/CT to planning CT in primary esophageal cancer.
原发性食管癌中,通过诊断性PET/CT与计划CT的可变形配准和刚性配准所定义的靶区体积的比较评估。
Medicine (Baltimore). 2017 Jan;96(1):e5528. doi: 10.1097/MD.0000000000005528.
4
Proton beam therapy for metastatic liver tumors.转移性肝肿瘤的质子束治疗
Radiother Oncol. 2015 Nov;117(2):322-7. doi: 10.1016/j.radonc.2015.09.011. Epub 2015 Sep 15.
5
Is there a survival benefit in interventional radiology for hepatocellular carcinoma in patients with Child-Pugh C liver cirrhosis?: A multicenter study.对于Child-Pugh C级肝硬化的肝细胞癌患者,介入放射学治疗是否具有生存获益?一项多中心研究。
Hepatol Res. 2016 May;46(6):521-8. doi: 10.1111/hepr.12583. Epub 2015 Oct 2.
6
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.肝细胞癌患者肝功能评估:一种基于新证据的方法——ALBI分级
J Clin Oncol. 2015 Feb 20;33(6):550-8. doi: 10.1200/JCO.2014.57.9151. Epub 2014 Dec 15.
7
Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy.质子束治疗的肝癌患者给药15分钟后吲哚菁绿的预处理保留率与生存预后的关系
Radiother Oncol. 2014 Oct;113(1):54-9. doi: 10.1016/j.radonc.2014.08.015. Epub 2014 Sep 20.
8
Validation of deformable image registration algorithms on CT images of ex vivo porcine bladders with fiducial markers.使用基准标记对离体猪膀胱CT图像上的可变形图像配准算法进行验证。
Med Phys. 2014 Jul;41(7):071916. doi: 10.1118/1.4883839.
9
Control over structure-specific flexibility improves anatomical accuracy for point-based deformable registration in bladder cancer radiotherapy.控制结构特异性灵活性可提高膀胱癌放射治疗中基于点的变形配准的解剖学准确性。
Med Phys. 2013 Feb;40(2):021702. doi: 10.1118/1.4773040.
10
The need for application-based adaptation of deformable image registration.基于应用的形变图像配准的调整需求。
Med Phys. 2013 Jan;40(1):011702. doi: 10.1118/1.4769114.